The capacity of DIANA Biotechnologies is 300,000 coronavirus tests per month, and the new line should at least double it. In an interview with E15, co-founder and COO Martin Dienstbier said DIANA Biotechnologies had leased new premises where the degree of automation should be greater, and was moving production there. The company is now developing a saliva test, the cost of which will be at least 50% lower, he said.
Source: CIA News
Prepared by the team of foreign office CzechTrade New York